An Expanded Access Program for AM0010 (Pegilodecakin)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.
- Status
- COMPLETED
- Phase
- PHASE1
SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
PD-L1 PET Imaging in Melanoma Patients
- Status
- COMPLETED
- Phase
- NA
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Circulating Tumor DNA Exposure in Peripheral Blood
- Status
- UNKNOWN
- Phase
- N/A
Skin Self-Examination Education During Mammography
- Status
- COMPLETED
- Phase
- NA
CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- N/A
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Phase I Study of BCD-145 (Anti-CTLA-4) in Patients With Unresectable/Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Melanoma Accuracy Study; Phase 2
- Status
- TERMINATED
- Phase
- N/A
A Study of BCD-135 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1